Package 55111-496-05
Brand: capecitabine
Generic: capecitabinePackage Facts
Identity
Package NDC
55111-496-05
Digits Only
5511149605
Product NDC
55111-496
Description
500 TABLET in 1 BOTTLE (55111-496-05)
Marketing
Marketing Status
Brand
capecitabine
Generic
capecitabine
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "25eb47d5-42ca-889b-6798-6f91d7795417", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0355111496601", "0355111497042"], "unii": ["6804DJ8Z9U"], "rxcui": ["200327", "200328"], "spl_set_id": ["007e3432-c8aa-2a76-52ba-c346924c08a7"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 BOTTLE (55111-496-05)", "package_ndc": "55111-496-05", "marketing_start_date": "20201210"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (55111-496-60)", "package_ndc": "55111-496-60", "marketing_start_date": "20201210"}], "brand_name": "capecitabine", "product_id": "55111-496_25eb47d5-42ca-889b-6798-6f91d7795417", "dosage_form": "TABLET", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "55111-496", "generic_name": "capecitabine", "labeler_name": "Dr. Reddy's Laboratories Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "capecitabine", "active_ingredients": [{"name": "CAPECITABINE", "strength": "150 mg/1"}], "application_number": "ANDA204345", "marketing_category": "ANDA", "marketing_start_date": "20201210", "listing_expiration_date": "20271231"}